Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
10/2008
10/09/2008WO2008120249A1 Pharmaceutical formulations based on apolar and polar lipids for ophthalmic use
10/09/2008WO2008120207A2 Compositions for nasal delivery
10/09/2008WO2008120101A2 The ed-a antigen of fibrinogen is associated with the neovasculature of tumour metastases
10/09/2008WO2008120098A2 Peptide prodrugs
10/09/2008WO2008120085A2 Angiogenic composition
10/09/2008WO2008119815A1 Subcutaneous administration of coagulation factor ix
10/09/2008WO2008119781A1 A method for improving the manufacturing process of a tumour vaccine
10/09/2008WO2008119401A1 Pharmaceutical formulations based on apolar and polar lipids for ophthalmic use
10/09/2008WO2008119260A1 A medicinal composition of carmustine, preparation method and application
10/09/2008WO2008119254A1 New use of coccidian
10/09/2008WO2008103264A3 Polymer particles
10/09/2008WO2008099190A3 Osteogenic compounds
10/09/2008WO2008074885A3 Process for manufacturing ophthalmic oil-in-water emulsions
10/09/2008WO2008071594B1 Polypeptides with the capacity to entrap drugs
10/09/2008WO2008067991A3 Skin-friendly drug complexes for transdermal administration
10/09/2008WO2008067127A3 Water insoluble polymer matrix for drug delivery
10/09/2008WO2008055146A3 Formulations of phospholipase enzyme inhibitors
10/09/2008WO2007107706A3 Dimers of heterocyclic compounds for the treatment of copd
10/09/2008WO2007095729A8 Cytotoxicity mediation of cells evidencing surface expression of cd63
10/09/2008WO2007089367A3 Use hedgehog kinase antagonists to inhibit hedgehog signaling and to treat cancer
10/09/2008WO2007041364A3 Conjugates for modulating the immune tolerance
10/09/2008WO2007021970A3 Stable pharmaceutical formulations and methods of use thereof
10/09/2008WO2007003898A8 Process for attaching effector molecules to proteins
10/09/2008US20080249497 Osmotically-driven fluid dispenser
10/09/2008US20080249486 Medicinal Composition with Active Ingredients and Wound Contact Layer with a Composition
10/09/2008US20080249485 Medicinal composition and wound contact layer with a composition
10/09/2008US20080249192 Anhydrous mixture of ester(s) of pentaerythritol, dipentaerythritol, and/or tripentaerythritol and partial glyceride(s) in a self-emulsifying base along with a nonionic and/or an anionic emulsifier having a HLB value of >10; cosmetics with high, stable viscosity unaffected by changes over time
10/09/2008US20080249191 Solubilizing composition
10/09/2008US20080249189 Used to enhance a sweet taste produced by a tastant such as sugar; e.g. ethyl 2-(3-methylbenzo[d]thiazol-2(3H)-ylideneamino)acetate, 2-(2-(2-methoxyphenoxy)ethylthio)-1H-benzo[d]imidazole; enhancers of TRPM5, a transient receptor potential (TRP) ion channel family member
10/09/2008US20080249147 Emulsion-Stabilized Preparation
10/09/2008US20080249076 slow release over an extended period of time and markedly increased bioavailability; significantly reduces food effect and may reduce side effects; dissolved in a solid vehicle or carrier and is especially suitable for oral solid dosage forms
10/09/2008US20080249074 Composition for the Transdermal Administration of Physiologically Active Agents
10/09/2008US20080249069 Method of treatment using bisphosphonic acid
10/09/2008US20080249044 Nucleic acid external skin formulation
10/09/2008US20080249041 Gene expression inhibition; sustained release; for reduction of neuronal cell death, inflammation, and scar formation; improves wound healing, skin rejuvenation and thickening
10/09/2008US20080248998 Glyceryl stearate or glyceryl palmitostearate to mask bad flavor of drugs; anti-bacterial, antifungal, metronidazole, anti-parasitic, nivaquine, antiviral, anti-cancer, analgesics, non-steroidal anti-inflammatories, anti-tussives, psychotropic, steroids, anti-histamines, anti-allergic agents
10/09/2008US20080248997 Modified g-protein coupled receptor for identifying modulators of taste preception; artificial sweeteners
10/09/2008US20080248996 T1r hetero-oligomeric taste receptors and cell lines that express said receptors and use thereof for identification of taste compounds
10/09/2008US20080248991 Chitosan Containing Solution
10/09/2008US20080248957 Herbicide, pesticide, parasiticide or miticide milled together with calcium carbonate, dispersants, surfactants and disintegrants in a water-soluble carrier chosen from acrylic ester-acrylamide copolymer, polyacrylic acid or crosslinked polysodium acrylate; gel or pastes; improved ease of application
10/09/2008US20080248579 Method of stabilizing human natriuretic peptides
10/09/2008US20080248571 Method of Production of Artificial Skin
10/09/2008US20080248564 Novel property effecting and/or property exhibiting compositions for therapeutic and diagnostic uses
10/09/2008US20080248544 Methods And Compositions For Grafting Functional Loops Into A Protein
10/09/2008US20080248125 biodegradable; vinyl methyl ether and maleic anhydride (PVM/MA) copolymer; excellent bioadhesion, size and zeta potential characteristics
10/09/2008US20080248124 Process for producing pharmaceutical composition
10/09/2008US20080248123 zolpidem, phenytoin; controlled release; surface modifier selected from anionic surfactants, cationic surfactants, zwitterionic surfactants, nonionic surfactants, surface active biological modifiers; hydroxypropyl methyl cellulose, hydrogenated oil or polyvinylpyrrolidone as rate controlling polymer
10/09/2008US20080248102 Rapidly Dissolving Pharmaceutical Compositions Comprising Pullulan
10/09/2008US20080248101 Pharmaceutical composition containing fenofibrate and method for the preparation thereof
10/09/2008US20080248098 Polysaccharide Microparticles Containing Biological Agents: Their Preparation and Applications
10/09/2008US20080248097 Polymeric micelles for combination drug delivery
10/09/2008US20080248088 Decontaminant edible product, methods of production and uses thereof
10/09/2008US20080248059 Dimensional Analysis of Saccharide Conjugates with Gpc & Sec-Mals
10/09/2008US20080248053 Antibody-drug conjugates; Auristatin peptides, including MeVal-Val-Dil-Dap-Norephedrine (MMAE) and MeVal-Val-Dil-Dap-Phe (MMAF); cancer; autoimmune diseases
10/09/2008US20080248051 Monomethylvaline compounds capable of conjugation to ligands
10/09/2008US20080248029 Prevention and treatment of amyloidogenic diseases
10/09/2008US20080248023 Treating and preventing amyloid A amyloidosis via enhancing immune response to amyloid A light-chain protein or serum amyloid A precursor protein
10/09/2008US20080248017 Multicompartment drug delivery system for use in treatment of menopausal symptoms and benign ovarian secretory disorder; contraceptive
10/09/2008US20080248014 Animal Medicament and Method of Manufacture
10/09/2008US20080247979 Use of a Hydrophobic Zeolite, that Contains and Gives a Slow Release of an Active Element, for Treatment of Skin
10/09/2008US20080247965 Metering valve and pressurized solution aerosol comprising bronchodilator, hydrofluorocarbon propellant, and cosolvent within container having inorganic coating
10/09/2008US20080247950 Proteases of human kallikrein 2 (hK2); tissue imaging
10/09/2008CA2702305A1 Cancer cell targeting using nanoparticles
10/09/2008CA2683217A1 Compositions for nasal delivery
10/09/2008CA2682670A1 A method of producing fast dissolving tablets
10/09/2008CA2682493A1 Targeting agent for cancer cell or cancer-associated fibroblast
10/09/2008CA2682376A1 Transpulmonary liposome for controlling drug arrival
10/09/2008CA2682199A1 Chloroplasts engineered to express pharmaceutical proteins in edible plants
10/09/2008CA2681712A1 Tamibarotene capsule preparation
10/09/2008CA2680536A1 Oral disintegrating tablet
10/08/2008EP1978095A1 Chimeric receptor proteins for controlling signal transduction and ligands binding thereto
10/08/2008EP1977766A1 Drug delivery material
10/08/2008EP1977765A1 Peptide prodrugs
10/08/2008EP1977764A1 Formulation of adenovirus for gene therapy
10/08/2008EP1977763A1 Antibody-containing stabilizing preparation
10/08/2008EP1977740A1 Composition comprising formoterol and a glucocorticosteroid
10/08/2008EP1977736A1 Oral pulsed dose drug delivery system
10/08/2008EP1977653A1 Method for gathering vegetable proteins and/or peptides, proteins and/or peptides produced through this method and usage thereof
10/08/2008EP1976904A1 New biodegradable polymers
10/08/2008EP1976876A1 Process for the production of preformed conjugates of albumin and a therapeutic agent
10/08/2008EP1976866A2 Fusion protein comprising a hiv nef double mutant and its use therapy
10/08/2008EP1976610A2 Thimerosal removal device
10/08/2008EP1976565A2 Immunostimulatory compositions and methods
10/08/2008EP1976564A2 Immuno-rna-constructs
10/08/2008EP1976563A2 Conjugates of a polypeptide and an oligosaccharide
10/08/2008EP1976562A1 Water-soluble films comprising low-viscosity alginates
10/08/2008EP1976561A2 Anti-infective solution comprising a compound of pyrido(3,2,1-ij)-benzoxadiazine type
10/08/2008EP1976539A2 Use of hyaluronic acid as a carrier molecule for different classes of therapeutic active agents
10/08/2008EP1976534A1 Sterilized nanoparticulate glucocorticosteroid formulations
10/08/2008EP1976531A1 Irradiated compositions and treatment of cancers with radiation in combination with taurolidine and/or taurultam
10/08/2008EP1858494B1 New soft gelatin capsules
10/08/2008EP1790357B1 Perorally administrable antimicrobial composition
10/08/2008EP1735321B1 Process for preparing rapamycin 42-esters and fk-506 32-esters with dicarboxylic acid, precursors for rapamycin conjugates and antibodies
10/08/2008EP1641486A4 Stable, aqueous solution of human erythropoietin, not containing serum albumin
10/08/2008EP1635875B1 In-situ gelling drug delivery system
10/08/2008EP1601359B1 Liquid pharmaceutical formulations of palonosetron
10/08/2008EP1592452B1 Invert emulsion type composition containing at least one active agent sensitive to the presence of water, and its uses in cosmetics and in dermatology
10/08/2008EP1511466B1 Use of glycosaminoglycans such as e.g. heparin for the treatment of respiratory disorders such as copd
10/08/2008EP1503732B1 Reduced formate poly(alkylene oxides) with reboxetine for reducing impurity formation
10/08/2008EP1499360B1 Formulation comprising buprenorphine
1 ... 633 634 635 636 637 638 639 640 641 642 643 644 645 646 647 648 649 650 651 652 653 ... 1712